Dirty Dozen Charts, Anthropic’s S-1, Amazon Earnings Preview, Cost of Capital Hits AI

The market landscape is shifting as the Anthropic S1 filing provides a much-needed boost to investor sentiment, revealing impressive revenue growth and manageable operating losses despite high capital expenditures. While the AI trade faced volatility due to rising capital costs, recent interest rate relief has stabilized the sector. Amazon emerges as a compelling opportunity, with AWS growth outpacing capital expenditure and a valuation multiple that remains attractive compared to other hyperscalers. Meanwhile, major tech firms like Meta are navigating a challenging environment by shifting toward equity financing, which introduces potential dilution concerns. Beyond the AI narrative, specific healthcare and industrial stocks—such as Thermo Fisher and Expeditors International—demonstrate strong technical setups with consistent higher highs and higher lows, offering alternative growth paths for investors looking beyond the primary AI-focused market leaders.